About Just Biotherapeutics
Just Biotherapeutics is a Healthcare company based in Seattle (United States) founded in 2014, and was acquired by Evotec in May 2019. Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs. Just Biotherapeutics has raised $123.51 million across 4 funding rounds from investors including Merck, Evotec and BOC. The company has 79 employees. Just Biotherapeutics offers products and services including Continuous Manufacturing Platform, CDMO Services, and Biomanufacturing Services. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Mammalian Cell Line. Its competitors include BigHat, Kodiak Sciences and Visterra; 3 of its 3 listed competitors have raised funding.
Company details
Just Biotherapeutics was founded in 2014 in Seattle, United States, within the biotechnology sector. Focus is placed on integrating protein design, process design, and manufacturing plant design to speed up clinical translation and cut costs in biotherapeutics. Services offered include molecular design, process design, drug product design, and plant design, supporting efficient development from concept to production.
- Headquarters Seattle, United States
- Employees 79
- Stage Acquired
- SectorsHealthcare
- Website justbiotherapeutics.com
- Social LinkedIn X
- Acquired by Evotec (May 2019)
Products & Services of Just Biotherapeutics
Just Biotherapeutics offers a comprehensive portfolio of products and services, including Continuous Manufacturing Platform, CDMO Services, and Biomanufacturing Services.
Platform for efficient biologics production using automated processes.
Services for antibody discovery and biomanufacturing from start to finish.
End-to-end solutions for clinical and commercial biologics supply.
Funding Insights of Just Biotherapeutics
Just Biotherapeutics has successfully raised a total of $123.51M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $35 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $123.51M
- Total Rounds 4
- Last Round Series B — $35M
- First Round $15M
(Sep 2015)
- Investors Count 11
All 4 funding rounds of Just Biotherapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2018 | $35M | Series B | – | Hillhouse | |
| Aug 2017 | $59.51M | Series B | – | Temasek | |
| Jul 2016 | $14M | Series A | – | Gates Foundation | |
| Sep 2015 | $15M | Series A | – | Merck, Lilly Asia Ventures | – |
12 investors in total: 12 institutional.
Investors in Just Biotherapeutics
Just Biotherapeutics has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck, Evotec and BOC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global private equity investments are managed with long-term focus. | hillhouseinvestment.com | New York, United States | ||
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
| bocgi-zs.com | ||||
Geintech Technologies is engaged in manufacturing high-standard communication cables. | hedaventures.com | Corona, United States | ||
| lillyasiaventures.com | ||||
Life insurance company | 1996 | taikang.com | Beijing, China | |
International commercial banking services are provided by Bank of China. | 1912 | boc.cn | Beijing, China | |
Commercial and retail banking along with investment services are provided. | 1996 | hccb.com.cn | Hangzhou, China | |
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States |
Investor details for Just Biotherapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Just Biotherapeutics
4 dated milestones of Just Biotherapeutics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Just Biotherapeutics is founded.
- Funding First funding round of $15.0M.
- Funding Latest funding round, Series B, of $35.0M.
- Exit Acquired by Evotec.
Competitors of Just Biotherapeutics
Just Biotherapeutics has 3 listed competitors in our database, 3 of them funded. They include BigHat, Kodiak Sciences and Visterra.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bighatbio.com | 2019 | San Carlos, United States | $148.41M | Antibody therapies are developed through machine learning and synthetic biology. | ||
| kodiak.com | 2009 | Palo Alto, United States | $35.84M | 112 | Therapeutics for retinal diseases are developed by the company. | |
| visterrainc.com | 2007 | Cambridge, United States | $116.17M | 79 | Developer of monoclonal antibodies against infectious diseases |
Detailed competitors of Just Biotherapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Just Biotherapeutics (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Just Biotherapeutics
Complete news archive for Just Biotherapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Just Biotherapeutics
Just Biotherapeutics was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Just Biotherapeutics is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Just Biotherapeutics is a funded company, having raised a total of $123.51M across 4 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Sep 2015.
Just Biotherapeutics has 79 employees.
Just Biotherapeutics was founded in 2014 in Seattle, United States, within the biotechnology sector. Focus is placed on integrating protein design, process design, and manufacturing plant design to speed up clinical translation and cut costs in biotherapeutics. Services offered include molecular design, process design, drug product design, and plant design, supporting efficient development from concept to production.
Just Biotherapeutics's top competitors include Kodiak Sciences, Visterra and BigHat.
Just Biotherapeutics offers Continuous Manufacturing Platform, CDMO Services, and Biomanufacturing Services.
Just Biotherapeutics has 12 investors. Key investors include Merck, Evotec, BOC, Gates Foundation, and Temasek.
Yes. Just Biotherapeutics was acquired by Evotec in May 2019.